“We want to be disciplined financially,” CEO Stéphane Bancel, told Barron’s. Moderna says it has 10 products it hopes to launch over the next few years, including a flu vaccine, a ...

The coronavirus will never disappear, Moderna CEO Stephan Bancel said during a panel earlier this week. “We are going to live with this virus, we think, forever,” he said. Separately ...

One of the closest-to-market among the 10 is mRNA-1283, a next-generation COVID vaccine. In his Monday letter, Bancel said the FDA has accepted Moderna’s application for the shot. Assisted by a ...

Moderna (MRNA) stock surged 7% this week following Oracle (ORCL) CEO Larry Ellison’s claims that artificial intelligence (AI) could help develop messenger RNA-based (mRNA) vaccines to cure cancer.

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

CEO Stéphane Bancel laid out a plan to reverse that. Moderna CEO Stéphane Bancel said in his 2024 shareholder letter published Monday that the past year brought "formidable challenges" for the ...

Shares plunge more than 24% in early trading 2025 revenue forecast misses expectations, prior view CEO Bancel says to reduce 2025 cash costs by $1 bln Jan 13 (Reuters) - Moderna (MRNA.O), opens ...

Moderna lost more than 20% of its value on the ... stressing savings as key to its goal of balancing cash flow by 2028. Ahead of CEO Stéphane Bancel’s address at the JP Morgan Healthcare ...

It expects to end 2025 with a cash balance of $6 billion. Moderna CEO Stephane Bancel commented, "In 2024, we achieved $3.0 - 3.1 billion in product sales, approval of our RSV vaccine and ...

In response, Moderna has slashed 2025 guidance twice in the past four months, most recently just eight days after CEO Stephane Bancel wrote in his Moderna 2024 Shareholder Letter that “There are ...

CEO Stéphane Bancel said Moderna has cut its "cash operating cost by over 25 percent compared to 2023" and plans to make further cost cuts of $1 billion in 2025 and $500 million more in 2026 ...